Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 19/20 | 0.47 |
| ▸ | HTR1B | P28222 | 19/20 | 0.47 |
| ▸ | HTR1A | P08908 | 17/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5369686 | 0.82 | HTR1D (0.69) | HTR1DHTR1BHTR1ACYP2C9CYP1A2 | |
| SCHEMBL5780220 | 0.79 | HTR1D (0.49) | HTR1DHTR1BHTR1ACYP2C9CYP1A2 | |
| SCHEMBL5369049 | 0.78 | HTR1D (0.51) | HTR1DHTR1BHTR1ACYP2C9CYP1A2 | |
| SCHEMBL25728287 | 0.69 | CHKA (0.59) | HTR1DHTR1BHTR1ACYP1A2 | |
| SCHEMBL31428715 | 0.68 | HRH3 (0.49) | CYP1A2 | |
| SCHEMBL27318436 | 0.66 | HRH3 (0.53) | CYP1A2 | |
| SCHEMBL6395392 | 0.66 | HTR1D (0.79) | HTR1DHTR1BHTR1ACYP2C9CYP1A2 | |
| SCHEMBL5216711 | 0.64 | HTR1D (0.81) | HTR1DHTR1BHTR1A | |
| SCHEMBL6394439 | 0.64 | HTR1D (0.84) | HTR1DHTR1BHTR1ACYP2C9CYP1A2 | |
| SCHEMBL24694886 | 0.63 | HRH3 (0.47) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1476444-B1 | HETEROCYCLIC COMPOUNDS POSSESSING AFFINITY AT 5HT1-TYPE RECEPTORS AND USE THEREOF IN THERAPY | GLAXO GROUP LTD (GB) | 2006-04-12 | — | — | EP | disclosed |
| EP-1476444-A1 | HETEROCYCLIC COMPOUNDS POSSESSING AFFINITY AT 5HT1-TYPE RECEPTORS AND USE THEREOF IN THERAPY | GLAXO GROUP LIMITED (GB) | 2004-11-17 | — | — | EP | disclosed |
| WO-2003068772-A1 | HETEROCYCLIC COMPOUNDS POSSESSING AFFINITY AT 5HT1-TYPE RECEPTORS AND USE THEREOF IN THERAPY | GLAXO GROUP LIMITED (GB) | 2003-08-21 | — | — | WO | disclosed |